Celldex Therapeutics reported $2.25B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Agenus USD 107M 16M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Celldex Therapeutics USD 2.25B 443M May/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Northwest Biotherapeutics USD 236M 120M May/2026
Pfizer USD 149.77B 4.04B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025